THYROCARE — Thyrocare Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Thyrocare Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,946	5,889	5,267	5,719	6,874
Cost of Revenue
Gross Profit	3,295	4,164	3,600	4,011	4,963
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,519	3,857	4,445	4,802	5,523
Operating Profit	1,428	2,032	822	917	1,351
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,525	2,277	886	960	1,454
Provision for Income Taxes
Net Income After Taxes	1,132	1,761	644	695	908
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,132	1,761	645	708	915
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,132	1,761	644	708	915
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	20.5	32.9	12.3	13.5	17.1
Dividends per Share